- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01166893
Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Researcher can use the combination of Modulated Imaging and Laser Speckle Imaging can be used as an adjuvant to standard clinical evaluation to gauge burn wound and severity of infection. Researcher can image the burn wounds of and compare with current standard of care, clinical exam, and can use the outcomes information in terms of time to healing and treatment
Modulating Imaging is a noninvasive optical modality measure the metabolic functions of the burn wound.
Laser Speckle Imaging is a noninvasive optical modality can measure blood flow of burn wound.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Gordon Kennedy, PhD
- Phone Number: 949-824-4713
- Email: gordon.kennedy@uci.edu
Study Locations
-
-
California
-
Orange, California, United States, 92868
- Recruiting
- UCIMC
-
Contact:
- Victor Joe, MD
- Phone Number: 714-456-5840
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male / female all age
- Subjects is an inpatient or out patient with burn wound
Exclusion Criteria:
- Subjects cannot lied flat and still for the duration of the imaging
- Subjects pregnant.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Burn wound
Modulated Imaging and Laser Speckle Imaging
|
wound healing
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Noninvasive burn wound severity assessment
Time Frame: 1 day
|
Noninvasive burn wound severity assessment using noncontact optical device
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anthony Durkin, PhD, University of California, Irvine
Study record dates
Study Major Dates
Study Start
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20097322
- R01GM108634 (U.S. NIH Grant/Contract)
Drug and device information, study documents
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.